Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Tuesday, May 1, 2007

A recently published review of Medicaid claims in Ohio between 1997 and 2002 showed that African American patients with newly diagnosed nonvalvular atrial fibrillation (AF) were 25% less likely to fill prescriptions for warfarin than their Caucasian counterparts. Clinical predictors of warfarin use for nonvalvular AF have been welldescribed in previous studies, but little is known about racial disparities in warfarin prescribing.

The main outcome measure of the study was the filling of a warfarin prescription at any time between 7 days prior to and 30 days after the diagnosis of AF. The authors identified 6283 patients with a new diagnosis of AF, 18.5% of whom were African American. Prescriptions were filled by 9.4% of Caucasian patients and 7.6% of African American patients. The 2 strongest predictors of filling the prescription were inpatient diagnosis of AF and having 2 or more outpatient visits in the year prior to diagnosis.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Having trouble getting your hands on FluMist?
Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.
Latest Issues